ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1656

Loss of Nr4a1 Expression Protects Cartilage During Post-traumatic Osteoarthritis

Katherine Escalera-Rivera, Jennifer Jonason and Jennifer Anolik, University of Rochester Medical Center, Rochester, NY

Meeting: ACR Convergence 2024

Keywords: Cartilage Degradation, Inflammation, Monocytes/macrophages, Mouse Models, Other, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: Osteoarthritis & Joint Biology – Basic Science

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Osteoarthritis (OA) is a complex disease involving pathological processes in joint tissues such as the cartilage and synovium. Cartilage is degraded by matrix metalloproteinases (MMPs) secreted by chondrocytes in response to inflammatory stimuli. Monocytes/macrophages also secrete MMPs and pro-inflammatory signals and are the most abundant immune cell type in the OA-inflamed synovium. Previous literature has shown that Nr4a1-expressing monocytes/macrophages are major secretors of MMPs. Data from the Accelerating Medicines Partnership (AMP) RA Phase I found that as the degree of synovial inflammation increases, multiple cell populations in the OA synovium, including monocytes/macrophages, upregulate the expression of the transcription factor Nr4a1. However, the role of Nr4a1 in cells within different joint tissues during OA is not yet fully understood.

Methods: We used flow cytometry to study the cellular heterogeneity in the synovium of a murine model of OA. To understand the role of Nr4a1 in monocytes/macrophages and other cells within the knee joint during OA, we performed MLI on Nr4a1 wild-type (WT), Nr4a1 Heterozygous (Het) and Nr4a1 Knockout (KO) littermate mice (WT n=3, Het n=4, KO n=6). Knee joints were harvested 4 weeks later for histology. In vitro studies using RT-qPCR were performed to assess the effects of loss of Nr4a1 in both ATDC5 chondrogenic cells transfected with Nr4a1 silencing RNA (siRNA) and primary Nr4a1 KO chondrocytes. Statistics were performed using unpaired Student’s t-test and One-way or Two-way ANOVA followed by Tukey’s post hoc test. Statistical significance was defined as p< 0.05.  

Results: We found a higher percentage of monocytes/macrophages in cells disaggregated from the synovium of C57BL6/J mouse knee joints subjected to meniscal/ligamentous injury (MLI) compared to sham joints (n=5, p< 0.05). Moreover, Nr4a1-GFP reporter mouse knee joints subjected to MLI showed a greater percentage of monocytes/macrophages expressing Nr4a1 than sham joints (n=5, p< 0.05). Histomorphometry showed a significant total tibial cartilage area loss in Nr4a1 WT compared to Het and KO knee joints (p< 0.01 and p< 0.05, respectively). Loss of Nr4a1 in both ATDC5 chondrogenic cells transfected with Nr4a1 silencing RNA (siRNA) and primary Nr4a1 KO chondrocytes resulted in a significant decrease in the gene expression of MMPs after IL-1ß stimulation. Interestingly, the expression of various pro-inflammatory genes increased significantly after IL-1ß stimulation in ATDC5 chondrogenic cells transfected with Nr4a1 siRNA.

Conclusion: Our findings indicate that monocytes/macrophages and chondrocytes express Nr4a1 during OA-related inflammation, and its downregulation reduces MMP gene expression in chondrocytes. This suggests that dampening MMP secretion, even in the presence of pro-inflammatory signals, could be protective for cartilage integrity in OA. Targeting Nr4a1 could be a potential strategy to explore this avenue.


Disclosures: K. Escalera-Rivera: None; J. Jonason: Lantheus, 2, Sanofi, 2, Vertex, 2; J. Anolik: None.

To cite this abstract in AMA style:

Escalera-Rivera K, Jonason J, Anolik J. Loss of Nr4a1 Expression Protects Cartilage During Post-traumatic Osteoarthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/loss-of-nr4a1-expression-protects-cartilage-during-post-traumatic-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/loss-of-nr4a1-expression-protects-cartilage-during-post-traumatic-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology